Status:
NOT_YET_RECRUITING
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
Lead Sponsor:
General Committee of Teaching Hospitals and Institutes, Egypt
Conditions:
Blood Loss
Intensive Care
Eligibility:
All Genders
Phase:
NA
Brief Summary
Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-ope...
Detailed Description
Surgical Technique and Preparation Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation, and Levofloxacin 500 mg intravenous injection will be administered...
Eligibility Criteria
Inclusion
- Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)
- Diagnosed by CT entero-colonography
- Diagnosed by colonoscopy
- Diagnosed by biopsy.
Exclusion
- Emergency surgery (obstruction, perforation with generalized peritonitis),
- Metastatic tumor diagnosed
- ASA score of IV or higher
- Need for more than one surgical procedure
- Conversion to open surgery
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 2 2030
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06049758
Start Date
January 2 2024
End Date
January 2 2030
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The surgical department of Medical Research Institute Hospital, Alexandria University
Alexandria, Egypt